IRIS
GRASSADONIA, Antonino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.467
EU - Europa 4.588
AS - Asia 3.746
Continente sconosciuto - Info sul continente non disponibili 530
SA - Sud America 526
AF - Africa 71
OC - Oceania 28
Totale 16.956
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.233
SG - Singapore 1.646
RU - Federazione Russa 1.076
CN - Cina 921
IT - Italia 860
IE - Irlanda 546
BR - Brasile 409
VN - Vietnam 404
SE - Svezia 380
FR - Francia 352
GB - Regno Unito 349
UA - Ucraina 345
DE - Germania 273
TR - Turchia 239
IN - India 133
HK - Hong Kong 109
CA - Canada 107
FI - Finlandia 91
BD - Bangladesh 57
LT - Lituania 52
PL - Polonia 51
JP - Giappone 44
MX - Messico 40
NL - Olanda 39
BE - Belgio 37
ES - Italia 34
AR - Argentina 31
CZ - Repubblica Ceca 29
IQ - Iraq 29
ZA - Sudafrica 28
CO - Colombia 23
AU - Australia 22
AT - Austria 21
IL - Israele 21
KR - Corea 18
VE - Venezuela 17
JM - Giamaica 15
EC - Ecuador 13
EG - Egitto 13
GT - Guatemala 13
PK - Pakistan 13
SA - Arabia Saudita 13
TT - Trinidad e Tobago 12
HN - Honduras 11
CR - Costa Rica 10
NI - Nicaragua 10
RO - Romania 10
UZ - Uzbekistan 10
ID - Indonesia 9
MY - Malesia 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
CL - Cile 8
JO - Giordania 8
PH - Filippine 8
PT - Portogallo 8
TW - Taiwan 8
PE - Perù 7
PY - Paraguay 7
EE - Estonia 6
MA - Marocco 6
NZ - Nuova Zelanda 6
SV - El Salvador 6
UY - Uruguay 6
BO - Bolivia 5
DZ - Algeria 5
EU - Europa 5
KZ - Kazakistan 5
OM - Oman 5
AL - Albania 4
KE - Kenya 4
NP - Nepal 4
TN - Tunisia 4
AZ - Azerbaigian 3
ET - Etiopia 3
GR - Grecia 3
IR - Iran 3
KW - Kuwait 3
LB - Libano 3
SC - Seychelles 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CI - Costa d'Avorio 2
GD - Grenada 2
GE - Georgia 2
GP - Guadalupe 2
KH - Cambogia 2
LU - Lussemburgo 2
MT - Malta 2
PS - Palestinian Territory 2
SN - Senegal 2
VG - Isole Vergini Britanniche 2
AF - Afghanistan, Repubblica islamica di 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
Totale 16.423
Salva come PNG Salva come JPEG
Città #
Singapore 1.266
San Jose 905
Chandler 657
Dublin 533
Ashburn 471
Jacksonville 438
Dallas 279
Beijing 258
Los Angeles 243
Council Bluffs 233
Princeton 203
Southend 166
Santa Clara 162
The Dalles 145
Izmir 134
Nanjing 128
Ho Chi Minh City 125
New York 109
Pescara 102
Hong Kong 100
Chieti 97
Buffalo 91
Wilmington 88
Dearborn 85
Ann Arbor 84
Altamura 83
North Bergen 83
Hanoi 77
Munich 76
Boardman 67
Cambridge 64
Phoenix 64
Tongling 60
Moscow 49
Rome 49
Columbus 45
Brooklyn 43
São Paulo 42
Denver 40
Dong Ket 40
Milan 40
Redondo Beach 39
Vilnius 39
Orem 38
Chicago 37
Nanchang 37
Tokyo 37
London 34
Montreal 34
Atlanta 33
Washington 33
Brussels 32
Nuremberg 32
Frankfurt am Main 31
Woodbridge 29
Houston 28
Hefei 27
Amsterdam 26
Warsaw 25
Da Nang 24
Brno 23
Hebei 22
Boston 21
Kunming 21
Shenyang 21
Stockholm 21
Norwalk 20
Tianjin 20
Johannesburg 19
Chennai 18
Jiaxing 18
Kraków 18
San Francisco 18
St Louis 18
Kansas City 17
Kimball 17
Mexico City 16
Helsinki 15
Memphis 15
Miami 15
Poplar 15
Seoul 15
Toronto 15
Charlotte 14
Falls Church 14
Turku 14
Changsha 13
Florence 13
Kingston 13
Lappeenranta 13
League City 13
Manchester 13
Naples 13
Philadelphia 13
Rio de Janeiro 13
Ancona 12
City of London 12
Melbourne 12
Mount Pleasant 12
Seattle 12
Totale 9.276
Salva come PNG Salva come JPEG
Nome #
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 928
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 457
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer 215
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 210
90K (Mac-2 BP) and galectins in tumor progression and metastasis. 206
Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis 200
Breast cancer "tailored follow-up" in Italian oncology units: A web-based survey 198
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience 191
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer. 190
The Role of the Environment and Type of Exercise on Acute Adrenal Modulation and Perceived Distress of Breast Cancer Survivors Practising Light-Intensity Physical Exercise 187
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 182
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients 181
A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate 179
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin 177
A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression 177
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 172
An Epigenetic Approach to Pancreatic Cancer Treatment: the Prospective Role of Histone Deacetylase Inhibitors 170
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 169
Gli analoghi sintetici delle glicoamine come potenziali nuovi farmaci nella prevenzione delle metastasi 166
Occupational allergy: is there a role for nanoparticles? 166
Exosomes as pleiotropic players in pancreatic cancer 166
A novel serum test using interferon for early detection of tumor reccurrence in cancer patients after radical surgery. 164
90k is a serum marker of poor-prognosis in non-hodgkins-lymphoma patients. 164
The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides. 163
Analisi dello stato mutazionale di K-RAS: un nuovo strumento per la selezione dei pazienti candidati a terapia con anticorpi anti-EGFR 160
Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells 160
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials 157
New Targets for Therapy in Pancreatic Cancer 155
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 154
Glicomimetici quali potenziali nuovi farmaci per la prevenzione delle metastasi. 153
A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate 152
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice. 150
Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 148
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 147
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer 146
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses 145
Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein. 145
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer 145
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 145
BIOLOGICAL INDICATORS OF PROGNOSIS IN HUMAN CANCER: AN EMERGING ROLE FOR LECTIN GALACTOSIDE-BINDING SOLUBLE 3-BINDING PROTEIN (LGALS3BP) 144
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 144
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial. 141
TGF-β-1 increases 90K tumor associated antigen gene expression by increasing upstream regulatory factor binding to the minimal promoter. 140
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 140
Identification of Subgroups of Early Breast Cancer Patients at High Risk of Nonadherence to Adjuvant Hormone Therapy: Results of an Italian Survey 140
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 139
Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage? Reply to Kadri Altundag 136
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study 136
The flavonoid quercetin inhibits thyroid-restricted genes expression and thyroid function. 134
Principali effetti collaterali delle terapie mediche 133
Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions. 132
Long-term outcome of breast cancer patients with pathologic N3a lymph node stage 132
Alectinib induced regression of renal and hepatic cysts caused by crizotinib 132
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 130
Drug repurposing, an attractive strategy in pancreatic cancer treatment: Preclinical and clinical updates 130
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression 130
Tumor-derived microvesicles: The metastasomes. 128
Prognostic value of gender and primary tumor location in metastatic colon cancer 128
Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies? 126
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 126
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 126
Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: A systematic review 125
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 124
Circadian timing of chemotherapeutic agents:a phase II study of 5-fluoro-2-deoxyuridine in gastrointestinal cancer and renal cell carcinoma 123
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer 122
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: A retrospective multicenter study 122
La stimolazione dinamica con IFN-α per la diagnosi precoce di ripresa di malattia in pazienti NED 121
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 121
The Crucial Role of Hereditary Cancer Panel Testing in Unaffected Individuals with a Strong Family History of Cancer: A Retrospective Study of a Cohort of 103 Healthy Subjects 120
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial 120
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer 118
Low Phosphatidylserine+ Cells Within the CD34+/CD45dim/CD117(c-kit)+ Subpopulation Are Associated with Poor Outcomes in Metastatic Colorectal Cancer 117
Regolazione, funzione ed espressione genica dell’antigene tumore-associato 90K/AC-2 BP 117
Relationships between daily physical activity combinations and psychophysical health status of Italian breast cancer survivors 116
Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer 115
Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expression. 113
Oral etoposide and platinum derivates in the treatment of metastatic Merkel cell carcinoma: report of three cases 113
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies 113
Possible role of thymidylate synthase level in hunan colorectal carcinoma: a new prognostic factor? 111
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective 111
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting 110
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial 110
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study 109
Flexibility and Strength Effects of Adapted Nordic Walking and Myofascial Exercises Practice in Breast Cancer Survivors and Analysis of Differences 109
Thyroglobulin autoregulation of thyroid-specific gene expression and follicular function 108
Neoadjuvant Chemotherapy for Surgically Staged IIIA N2 Non-Small Cell Lung Cancer (NSCLC) in the Elderly 107
Effect of taxanes following anthracyclines on pathologic complete response (pCR) in patients with triple-negative breast cancer (TNBC) receiving primary systemic therapy (PST). 107
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 107
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study 104
Prognostic value of a novel interferon-inducible 90K tumor antigen 104
Impact of Body Mass Index (BMI) on outcome of metastatic breast cancer (MBC) patients (pts) treated with Eribulin in a real-world population: a multicenter retrospective study 104
Thymidylate synthase level and DNA-ploidy pattern as possible prognostic factors in human colorectal cancer: a preliminary study 103
Pretreatment neutrophil-lymphocyte ratio (NLR) predicted overall survival (OS) for metastatic melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC) patients who received monotherapy with immune checkpoint inhibitor as ipilimumab, nivolumab and pembrolizumab 103
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study. 102
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 102
FPSE-HPLC-DAD metod for the quantification of anticancer drugs in human whole blood, plasma and urine 101
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting 100
Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer 99
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer 99
Current challenges in HER2-positive breast cancer 99
Totale 14.916
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.905
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022400 0 0 0 0 34 32 15 46 33 15 62 163
2022/20231.842 143 236 160 191 190 329 98 155 210 16 70 44
2023/20241.029 86 31 66 44 64 329 173 30 41 33 25 107
2024/20252.361 137 390 324 109 61 118 116 125 223 176 257 325
2025/20265.937 400 199 498 553 543 330 978 293 1.204 482 319 138
2026/20272.136 223 435 482 776 220 0 0 0 0 0 0 0
Totale 16.956